Skip to content
Clinical Trial Events
MAGI@home 2026

Talk Quality/Regulatory track

Responsible AI: Governance, Oversight & “Who Reviewed the Robot?”

Tue, Oct 20, 2026 · 1:00–2:00 PM EDT

About this session

When an AI-assisted document ends up in a regulatory submission or a trial master file, someone must be accountable for its accuracy. This session addresses the governance infrastructure required to use AI responsibly in a regulated environment. We'll discuss the essential elements: an inventory of approved tools and use cases, defined human review requirements proportional to risk, documentation of who reviewed what, validation expectations, and clear escalation paths when output is wrong. We'll examine how existing quality management systems, SOPs, and vendor oversight frameworks can be extended to cover AI rather than rebuilt from scratch, and consider the emerging regulatory signals from FDA, EMA, and data protection authorities. Practical rather than theoretical — attendees will leave with a governance checklist.

Takeaways

Build an AI use inventory and risk-tier framework for your organization

Define proportionate human oversight and documentation requirements

Extend existing QMS and vendor oversight processes to cover AI tools

Speakers

Reviews of this session

No reviews yet

Were you in the room? Reviews are open until Oct 23, 2027.

Write the first review